Early prediction and prevention of venous thromboembolism is crucial in high-risk populations, such as hospitalized patients with bladder cancer.
KalVista Pharmaceuticals remains a Hold as the stock underperforms post-Ekterly launch. Read my latest analysis of KALV stock ...
Guidelines regarding the management of cardiovascular disease in pregnant patients have been published by the European Society of Cardiology.